Graham Ogg

Grey Wolf Therapeutics Ltd. is a biotechnology company, which engages in the drug discovery in immuno-oncology. It targets endoplasmic reticulum aminopeptidases 1 and 2 in the antigen presentation pathway to drive modulation of the neoantigen repertoire on tumour cells. The company was founded by Thomas D. McCarthy and Peter Joyce and is headquartered in Oxford, the United Kingdom.

GlycoFi, Inc. develops biopharmaceutical products. It provides protein production technology to develop, produce and commercialize biotherapeutics products. The company was founded by Tillman Gerngross in 2000 and is headquartered in Lebanon, NH.

M2S, Inc. engages in the provision of medical image and data management services. It offers technology and services to the healthcare industry to manage clinical information, reduce costs, and improve the quality of patient care. The company was founded by Charles E. Hutchinson and David T. Chen in 1997 and is headquartered in West Lebanon, NH.

Ovation Life Sciences LLC develops next-generation scientific data-layer-as-a-service platforms. Its main products are a lab service for the tracking of samples, workflows, and processes, and a research service for facilitating collaboration and data sharing between separate teams. The company was founded by Barry Wark and Winston Brasor in 2009 and is headquartered in Cambridge, MA.

Iclectus Ltd. develops antibody and therapeutic products. It is a pharmaceutical firm. It specializes in the research and development of antibodies. It is located in London, UK.

MedImmune Ltd. engages in research, development and exploitation of products in the field of molecular engineering. The company was founded on December 11, 1989 and is headquartered in Cambridge, the United Kingdom.

Part of Perrigo Co. Plc, Quadrant Healthcare Plc is a British company that researches, develops, and formulates drugs. The company is based in Cambridge, UK. Quadrant Healthcare was acquired by Elan Europe Ltd. on January 11, 2001 for $69.60 million.

Monash University operates as a public research university. It specializes in higher education, global engagement, postgraduate courses, undergraduate study, and PhD research. The company was founded on March 1961 and is headquartered in Clayton, Australia.

Pathios Therapeutics Ltd. engages in discovering and developing novel small molecule drugs. The company was founded by Thomas David McCarthy, Alan Naylor, Kirsty McCarthy, Peter Joyce and Someit Sidhu in 2017 and is headquartered in Oxford, the United Kingdom.

Amagma, Inc. provides healthcare services. The company is headquartered in Waltham, MA.

Brandon Capital Partners Pty Ltd. (Brandon Capital Partners) is a venture capital firm founded in 2007 by David Fisher and Chris Nave. The firm is headquartered in Sydney, Australia.

Valiance Life Science Investments (Valiance Life Science Investments) is a private equity subsidiary of Valiance Asset Management Ltd. founded in 2017. The firm headquartered in London, United Kingdom.

Oxford Science Enterprises PLC (Oxford Science Enterprises) is a venture capital firm founded in 2015. The firm is headquartered in Oxford, United Kingdom.

Nordic Capital Ltd. (Nordic Capital) is a private equity subsidiary of Triona Holding SA founded in 1989 by Robert Andreen and Morgan Olsson. The firm is headquartered in St Hellier, New Jersey.

CIRCADIAN Therapeutics Ltd. develops drugs that derive therapeutic effects through modulation of the control of sleep and circadian rhythm. The company was founded by Chris Blackwell, Russell Foster, Maarten De Vos, A. Jagannath, and S. Vasudevanis on July 18, 2016 and is headquartered in Oxford, the United Kingdom.

Enzbond Ltd. engages in research and development on natural sciences and engineering. The firm specializes in enzyme discovery. The company was founded by Alina Rakhimova and Robert Simion and is headquartered in Oxford, the United Kingdom.

Proxisense Ltd. develops proximity sensors and fluid contamination systems for use in extreme environments. The company was founded on September 16, 2014 and is headquartered in Haslemere, the United Kingdom.

Metaboards Ltd. manufactures magneto devices and develops software application. It specializes in medical devices, consumer electronics, aerospace and defence, clothing and fabrics. The company was founded by Ekaterina Shamonina and is headquartered in Oxford, the United Kingdom.

Iota Sciences Ltd. develops fluid-shaping technology for life sciences and biomedicine, offering innovative solutions for ambitious research. The company was founded by Peter Cook, Edmond Walsh and Alexander Feuerborn in 2016 and is headquartered in Oxford, the United Kingdom.

Argonaut Therapeutics Ltd. develops novel epigenetic therapies. It targets abnormal arginine methylation in cancer. The company was founded by Nicholas La Thangue and is headquartered in Oxford, the United Kingdom.

Opsydia Ltd. manufactures and distributes laser cutting machinery. Its applications include diamond, media and sensors. The company was founded by Patrick Salter and Martin Booth in September 2017 and is headquartered in Begbroke, the United Kingdom.

BibliU Ltd. operates an online platform that provides students with access to their textbooks and libraries with affordable core textbook packages. The company was founded by Dave Sherwood, Ellis Gecan, Tao Mantaras and Daniel Engelke and is headquartered in London, the United Kingdom.

T-Cypher Bio Ltd. is a British biotechnology company. The company was founded in 2015. Thomas Lars Andresen has been the CEO of the company since 2021.

Ankyra Therapeutics, Inc. engages in the provision of healthcare services. The company is headquartered in Boston, MA.

Blacksmith Medicines, Inc. is a pharmaceutical company based in San Diego, CA and has subsidiaries in the United States. Blacksmith Medicines is focused on developing medicines that target metal-dependent enzymes found in human physiology. The company's platform combines a focused library of metal-binding pharmacophores with proprietary computational modeling approaches to rapidly and rationally design small molecule inhibitors that interact with key metal ions in the enzymes active site. The company recognized a large unmet need for new chemical matter and innovative approaches to drug this important class of enzymes. The company was founded by Zachary A. Zimmerman and has been led by him as the CEO since incorporation.

Pharminox Ltd develops treatments for cancer therapy. The private company is based in Abingdon, UK. The British company was founded by Neil L. Brown.

Nanotether Discovery Science Ltd. engages in the discovery of new medicines by accelerating the progression of potential drug candidates. The company was founded by Trevor Dale, Adrian Harwood and Paola Borri in 2012 and is headquartered in Cardiff, the United Kingdom.

Research Support International Pvt Ltd. provides drug discovery & development services. Its facilities include analytical, synthetic, kilo, hydrogenation, humidity control and hazardous reactions labs. The company is headquartered in Thane, India.

Forge Therapeutics, Inc. manufactures pharmaceutical products. It is a biotechnology company developing novel medicines by combining bio-inorganic with medicinal chemistry to target metalloproteins. The company was founded by Zachary A. Zimmerman, Seth Cohen and David Puerta and is headquartered in San Diego, CA.

Exscientia AI Ltd. is an artificial intelligence (AI) driven pharmatech company, which develops bi-specific small molecule immuno-oncology therapeutics. The firm offers phenotypic drug design and selective single target molecules. The company was founded by Andrew Lee Hopkins in July 2012 and is headquartered in Oxford, the United Kingdom.

Part of Evotec SE, Cyprotex Discovery Ltd. is a British company that specializes in in vitro toxicology studies using a range of techniques such as cell-based assays, mass spectrometer, fluorescence imaging, and qrt-pcr endpoints. The company is based in Abingdon, UK. The company also offers mitochondrial toxicity assays including seahorse assay, glu/gal assay, mitochondrial biogenesis, mitochondrial membrane potential, and mitochondrial mass.

Part of Evotec SE, Evotec (UK) Ltd. provides research and development on natural sciences and engineering. The company is based in Abingdon, UK and was founded in 1991.

Part of Evotec SE, Aptuit (Oxford) Ltd. is a British pharmaceutical company that manufactures pharmaceutical products. The company is based in Abingdon, UK.

Part of Evotec SE, Evotec (München) GmbH is a German company that provides manufacturing and research support services for pharmaceutical and biotechnology companies. The company is based in Neuried, Germany. The CEOs are Dirk Ullmann, Loëtitia Edith Rouxel. The company was founded in 2005 by Axel Ullrich, Hellmut Kirchner, Henrik Daub. Evotec (München was acquired by Evotec SE on April 19, 2011 for $20.40 million.

Evotec International GmbH develops and provides drugs for the treatment of CNS disorders. It focuses on Alzheimer's disease and other neurological disorders. The company was founded in 1999 and is headquartered in Hamburg, Germany.